See in this edition of Life Sciences & Healthcare Newsletter:
-
Anvisa Updates 2024-2025 Regulatory Agenda with the Inclusion of Eight New Topics
-
Anvisa Creates Repository Compiling Fully Recognized Claims in Foods
-
Anvisa Addresses and Takes Action Related to Subcutaneous Hormonal Implants
-
Anvisa Establishes the AnvisaLegis System
-
Anvisa Approves Framework for Clinical Research Rules
-
ANS Temporarily Suspends Rules Related to Failure to Pay Health Plans
-
Bioinputs Bill Is Approved and Awaits Presidential Sanction
To check out the full content, please click here.
